These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 12881373)

  • 21. The Gothenburg breast screening trial: first results on mortality, incidence, and mode of detection for women ages 39-49 years at randomization.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Eriksson O; Hafström LO; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säve-Söderbergh J
    Cancer; 1997 Dec; 80(11):2091-9. PubMed ID: 9392331
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Mammographic breast cancer screening. Part II. Non-randomised comparisons: results similar to those of randomised trials.
    Prescrire Int; 2015 Apr; 24(159):99-102. PubMed ID: 25941706
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Controversies in screening with mammography.
    Larsson LG
    Acta Oncol; 1997; 36(7):675-9. PubMed ID: 9490082
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Pan-Canadian study of mammography screening and mortality from breast cancer.
    Coldman A; Phillips N; Wilson C; Decker K; Chiarelli AM; Brisson J; Zhang B; Payne J; Doyle G; Ahmad R
    J Natl Cancer Inst; 2014 Nov; 106(11):. PubMed ID: 25274578
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The Gothenburg Breast Cancer Screening Trial: preliminary results on breast cancer mortality for women aged 39-49.
    Bjurstam N; Björneld L; Duffy SW; Smith TC; Cahlin E; Erikson O; Lingaas H; Mattsson J; Persson S; Rudenstam CM; Säwe-Söderberg J
    J Natl Cancer Inst Monogr; 1997; (22):53-5. PubMed ID: 9709276
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Report of the International Workshop on Screening for Breast Cancer.
    Fletcher SW; Black W; Harris R; Rimer BK; Shapiro S
    J Natl Cancer Inst; 1993 Oct; 85(20):1644-56. PubMed ID: 8105098
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Efficacy of screening mammography among women aged 40 to 49 years and 50 to 69 years: comparison of relative and absolute benefit.
    Kerlikowske K
    J Natl Cancer Inst Monogr; 1997; (22):79-86. PubMed ID: 9709281
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Breast cancer screening: a summary of the evidence for the U.S. Preventive Services Task Force.
    Humphrey LL; Helfand M; Chan BK; Woolf SH
    Ann Intern Med; 2002 Sep; 137(5 Part 1):347-60. PubMed ID: 12204020
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Canadian National Breast Screening Study: 2. Breast cancer detection and death rates among women aged 50 to 59 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1477-88. PubMed ID: 1423088
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Canadian National Breast Screening Study: 1. Breast cancer detection and death rates among women aged 40 to 49 years.
    Miller AB; Baines CJ; To T; Wall C
    CMAJ; 1992 Nov; 147(10):1459-76. PubMed ID: 1423087
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Mammography in symptomatic and asymptomatic patients.
    Stomper PC; Gelman RS
    Hematol Oncol Clin North Am; 1989 Dec; 3(4):611-40. PubMed ID: 2691492
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Updated results of the Gothenburg Trial of Mammographic Screening.
    Bjurstam NG; Björneld LM; Duffy SW
    Cancer; 2016 Jun; 122(12):1832-5. PubMed ID: 27061821
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Updated overview of the Swedish Randomized Trials on Breast Cancer Screening with Mammography: age group 40-49 at randomization.
    Larsson LG; Andersson I; Bjurstam N; Fagerberg G; Frisell J; Tabár L; Nyström L
    J Natl Cancer Inst Monogr; 1997; (22):57-61. PubMed ID: 9709277
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Advanced breast cancer and breast cancer mortality in randomized controlled trials on mammography screening.
    Autier P; Héry C; Haukka J; Boniol M; Byrnes G
    J Clin Oncol; 2009 Dec; 27(35):5919-23. PubMed ID: 19884547
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mammographic screening in women with a family history of breast cancer: some results from the Swedish two-county trial.
    Nixon RM; Pharoah P; Tabar L; Krusemo UB; Duffy SW; Prevost TC; Chen HH
    Rev Epidemiol Sante Publique; 2000 Aug; 48(4):325-31. PubMed ID: 11011299
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Evaluation of The Netherlands breast cancer screening programme.
    Verbeek AL; Broeders MJ; ;
    Ann Oncol; 2003 Aug; 14(8):1203-5. PubMed ID: 12881378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Reduced breast cancer mortality after 20+ years of follow-up in the Swedish randomized controlled mammography trials in Malmö, Stockholm, and Göteborg.
    Nyström L; Bjurstam N; Jonsson H; Zackrisson S; Frisell J
    J Med Screen; 2017 Mar; 24(1):34-42. PubMed ID: 27306511
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The impact of organized mammography service screening on breast carcinoma mortality in seven Swedish counties.
    Duffy SW; Tabár L; Chen HH; Holmqvist M; Yen MF; Abdsalah S; Epstein B; Frodis E; Ljungberg E; Hedborg-Melander C; Sundbom A; Tholin M; Wiege M; Akerlund A; Wu HM; Tung TS; Chiu YH; Chiu CP; Huang CC; Smith RA; Rosén M; Stenbeck M; Holmberg L
    Cancer; 2002 Aug; 95(3):458-69. PubMed ID: 12209737
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Mammographic screening of women aged 40 to 49 years. Is it justified?
    Feig SA
    Obstet Gynecol Clin North Am; 1994 Dec; 21(4):587-606. PubMed ID: 7731636
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Differences in endpoints between the Swedish W-E (two county) trial of mammographic screening and the Swedish overview: methodological consequences.
    Holmberg L; Duffy SW; Yen AM; Tabár L; Vitak B; Nyström L; Frisell J
    J Med Screen; 2009; 16(2):73-80. PubMed ID: 19564519
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.